UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000014429
Receipt No. R000016794
Scientific Title Investigation for Association of Adiponectin and Acute Coronary Syndrome
Date of disclosure of the study information 2020/01/01
Last modified on 2020/01/14 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Investigation for Association of Adiponectin and Acute Coronary Syndrome
Acronym i4ACS
Scientific Title Investigation for Association of Adiponectin and Acute Coronary Syndrome
Scientific Title:Acronym i4ACS
Region
Japan

Condition
Condition Acute myocardial infarction, Angina pectoris
Classification by specialty
Cardiology Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the significance of circulating factors relating to life style-associated diseases.
Basic objectives2 Others
Basic objectives -Others To clarify the difference of concentrations in circulating factors in coronary and aortic blood
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Significance of circulating factors relating to life style-associated diseases.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Subjects who were diagnosed as acute myocardial infection or angina pectoris, and then treated by PCI. Subjects agreed with study protocol.
Key exclusion criteria (1) Cases with significant stenosis in the left main trunk (LMT) or with post-CABG or with post-intracoronary stenting or with pioglitazone treatment.
(2) Subjects who were judged inadequate for the study by the attending physician.
Target sample size 200

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Iichiro Shimomura
Organization Graduate School of Medicine, Osaka University
Division name Department of Metabolic Medicine
Zip code
Address 2-2-B5, Yamada-oka, Suita, Osaka, Japan
TEL 06-6879-3737
Email ichi@endmet.med.osaka-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Norikazu Maeda
Organization Graduate School of Medicine, Osaka University
Division name Department of Metabolic Medicine
Zip code
Address 2-2-B5, Yamada-oka, Suita, Osaka, Japan
TEL 06-6879-3737
Homepage URL
Email norikazu_maeda@endmet.med.osaka-u.ac.jp

Sponsor
Institute Department of Metabolic Medicine,
Graduate School of Medicine, Osaka
University
Institute
Department

Funding Source
Organization Department of Metabolic Medicine,
Graduate School of Medicine, Osaka
University
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 01 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 08 Month 15 Day
Date of IRB
2013 Year 08 Month 15 Day
Anticipated trial start date
2013 Year 08 Month 15 Day
Last follow-up date
2017 Year 10 Month 30 Day
Date of closure to data entry
2017 Year 10 Month 30 Day
Date trial data considered complete
Date analysis concluded
2017 Year 10 Month 30 Day

Other
Other related information Measurement of adipocytokines, oxidative stresses, and factors relating to atherosclerosis.

Management information
Registered date
2014 Year 06 Month 30 Day
Last modified on
2020 Year 01 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000016794